ArticleWorld journal of urology2021

Comparing the prediction of prostate biopsy outcome using the Chinese Prostate Cancer Consortium (CPCC) Risk Calculator and the Asian adapted Rotterdam European Randomized Study of Screening for Prostate Cancer (ERSPC) Risk Calculator in Chinese and European men.

Rui Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.